|Bid||942.350 x 200|
|Ask||943.290 x 400|
|Day's Range||932.110 - 944.860|
|52 Week Range||610.710 - 963.540|
|PE Ratio (TTM)||47.44|
|Earnings Date||Jul 20, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||884.47|
In a previous note, we talked about how Intuitive Surgical can be a $1,000 stock. To justify such a price, the company will need to maintain gross margins in the 70% range, sell nearly 800 da Vinci systems annually by the end of 2023, and grow its average accessory spend per unit to nearly $500k.
Intuitive Surgical's da Vinci Sp is the latest technological innovation in the company’s surgical systems.
On May 30, 2017, Intuitive Surgical (ISRG) announced that it received FDA (US Food and Drug Administration) approval of its new da Vinci X robotic surgical system.